Form 4: InspireMD Director Gary S. Roubin Acquires Shares and Warrants
SEC Form 4
Director Gary S. Roubin acquired shares and warrants of InspireMD, Inc. on May 28, 2024.
Summary
- On May 28, 2024, Gary S. Roubin, a director of InspireMD, Inc., acquired 30,625 shares of common stock at a price of $1.3827 per share.
- Following this transaction, Roubin directly owns 501,788 shares of InspireMD, Inc.
- Roubin also acquired warrants to purchase 30,625 shares of common stock with an exercise price of $1.3827, expiring on June 26, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It reflects routine insider trading activity. The director's purchase could be seen as a positive signal, but it's not overwhelmingly significant.
Positives
- A director's increased investment in the company may signal confidence in its future prospects.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's prospects.
Stakeholder Impact
- Shareholders may view the director's purchase as a positive sign, potentially increasing investor confidence.
Key Dates
| Date | Description |
|---|---|
| 05/15/2023 | Date Series H Warrant exercisable |
| 05/28/2024 | Date of transaction: acquisition of shares and warrants. |
| 05/30/2024 | Date of signature on the Form 4. |
| 06/26/2024 | Expiration date of the Series H Warrant. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.